Insurance Denied Your Parkinson's Treatment? How to Appeal DBS and Medication Denials

Parkinson's disease is a progressive neurological disorder affecting more than one million Americans. When symptoms advance beyond what oral medications can control, treatments like deep brain stimulation (DBS) become medically necessary — not experimental. Yet insurers routinely deny DBS and other advanced Parkinson's therapies, leaving patients without critical care while their disease progresses. Every week of delay can mean irreversible functional decline.

Why Insurers Deny Parkinson's Treatments

• "Investigational or experimental" label on DBS: The FDA approved DBS for Parkinson's disease in 1997 and for advanced tremor control in 2002. More than 200,000 patients worldwide have received DBS implants. Labeling it experimental is clinically indefensible.
• "Not medically necessary": The insurer claims oral medications haven't been adequately trialed, even when the patient has documented motor fluctuations and dyskinesias
• Step therapy violations: Requiring failure of additional medication combinations before DBS is approved, despite MDS guidance that DBS is appropriate once motor complications emerge
• Out-of-network neurosurgeon or DBS center: Specialized DBS centers may not be in every network
• Lack of Prior Authorization Denied: How to Appeal" class="auto-link">prior authorization: Used to deny retroactively even clearly appropriate cases

Common denial codes: CO-50 (not medically necessary), CO-97 (procedure bundled), N-130 (requires preauthorization).

How to Appeal a Parkinson's Treatment Denial

Step 1: Obtain the Denial Documentation and Clinical Criteria

Request your EOB)" class="auto-link">Explanation of Benefits (EOB) and ask for the insurer's clinical criteria — often called "coverage determination guidelines" or "medical policies" — used to deny your claim. Under ERISA (29 U.S.C. § 1133), the insurer must provide these documents.

Step 2: Challenge the "Experimental" Designation with FDA Evidence

DBS devices from Medtronic, Abbott, and Boston Scientific carry PMA approvals and 510(k) clearances for Parkinson's disease. Cite the specific FDA approval dates (1997 and 2002 clearances) in your appeal. Your insurer's policy definition of "experimental" almost certainly requires that no professional organization recognizes the procedure — which is directly contradicted by both FDA clearance and specialty society endorsement.

Step 3: Cite MDS and AAN Clinical Guidelines

The Movement Disorder Society (MDS) Task Force guidelines categorize DBS as a Category A, Level I intervention — the highest level of evidence — for patients with advanced Parkinson's experiencing motor fluctuations, dyskinesias, or disabling tremor despite optimized medical therapy. The American Academy of Neurology (AAN) similarly endorses DBS as standard of care for appropriately selected patients. Medicare coverage under LCD criteria further establishes commercial insurance must recognize DBS as non-experimental.

Step 4: Have a Movement Disorder Specialist Write a Medical Necessity Letter

The letter should include ICD-10 G20.A1–G20.C2 (Parkinson's staging), documented motor complications (on/off fluctuations, dyskinesias), all medications trialed and their outcomes, UPDRS (Unified Parkinson's Disease Rating Scale) scores documenting functional impairment, and explicit statement of why DBS is not experimental citing FDA approval.

Step 5: Request Peer-to-Peer Review

Ask that the insurer's reviewing physician (likely a generalist) speak directly with the prescribing movement disorder specialist. The complexity of Parkinson's management makes peer-to-peer conversations particularly effective for DBS authorization.

Step 6: File for External Independent Medical Review

Request external IMR if the internal appeal fails. For neurological conditions with clear clinical guidelines like DBS for Parkinson's, External Independent Review: Complete Guide" class="auto-link">external reviewers with neurology expertise frequently overturn "experimental" designations.

What to Include in Your Appeal

• FDA approval documentation for the specific DBS system (PMA number and clearance date)
• MDS Task Force guidelines citing Category A, Level I classification for DBS
• Movement disorder specialist letter with UPDRS scores, motor complication documentation, and medication trial history
• Video recordings of motor symptoms (on/off cycles) if available
• Second opinion from a second movement disorder specialist confirming DBS candidacy

Fight Back With ClaimBack

Insurance companies count on patients and families being too overwhelmed to fight back. When DBS is denied as "experimental" despite FDA clearance and MDS guidelines, appeals succeed at high rates with the right clinical documentation. ClaimBack generates a professional appeal letter in 3 minutes. Start your free claim analysis → Free analysis · No credit card required · Takes 3 minutes

Related Reading

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs External Insurance Appeal